Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Proton therapy in clinical practice.

Liu H, Chang JY.

Chin J Cancer. 2011 May;30(5):315-26. Review.

2.

Proton therapy in the clinic.

DeLaney TF.

Front Radiat Ther Oncol. 2011;43:465-85. doi: 10.1159/000322511. Epub 2011 May 20. Review.

PMID:
21625169
3.

A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.

Weber DC, Trofimov AV, Delaney TF, Bortfeld T.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1596-606.

PMID:
15050341
4.

Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.

Wang X, Krishnan S, Zhang X, Dong L, Briere T, Crane CH, Martel M, Gillin M, Mohan R, Beddar S.

Med Dosim. 2008 Winter;33(4):259-67. doi: 10.1016/j.meddos.2007.04.008.

PMID:
18973852
5.

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, Loeffler J, Clasie B, Safai S, Paganetti H.

Radiother Oncol. 2008 Feb;86(2):148-53. doi: 10.1016/j.radonc.2007.12.024. Epub 2008 Jan 30.

PMID:
18237800
6.

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

Trofimov A, Nguyen PL, Coen JJ, Doppke KP, Schneider RJ, Adams JA, Bortfeld TR, Zietman AL, Delaney TF, Shipley WU.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):444-53. Epub 2007 May 21.

7.

Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.

Roelofs E, Engelsman M, Rasch C, Persoon L, Qamhiyeh S, de Ruysscher D, Verhaegen F, Pijls-Johannesma M, Lambin P; ROCOCO Consortium..

J Thorac Oncol. 2012 Jan;7(1):165-76. doi: 10.1097/JTO.0b013e31823529fc.

9.

Proton beams to replace photon beams in radical dose treatments.

Suit H, Goldberg S, Niemierko A, Trofimov A, Adams J, Paganetti H, Chen GT, Bortfeld T, Rosenthal S, Loeffler J, Delaney T.

Acta Oncol. 2003;42(8):800-8.

PMID:
14968940
10.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1087-96. Epub 2006 May 6.

PMID:
16682145
11.

Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.

Barten DL, Tol JP, Dahele M, Slotman BJ, Verbakel WF.

Med Phys. 2015 Nov;42(11):6589-98. doi: 10.1118/1.4933245.

PMID:
26520750
12.

[Initial clinical experience of proton therapy at Shizuoka Cancer Center].

Murayama S, Fuji H, Yamashita H, Futami Y, Numano M, Harada H, Kamata M, Nishimura T.

Nihon Igaku Hoshasen Gakkai Zasshi. 2005 Oct;65(4):424-31. Japanese.

PMID:
16334397
13.

Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.

Baumert BG, Norton IA, Lomax AJ, Davis JB.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1314-24.

PMID:
15519805
14.

Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.

Weber DC, Zilli T, Vallee JP, Rouzaud M, Miralbell R, Cozzi L.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e311-8. doi: 10.1016/j.ijrobp.2012.03.028.

PMID:
22999271
15.

Practice patterns of photon and proton pediatric image guided radiation treatment: results from an International Pediatric Research consortium.

Alcorn SR, Chen MJ, Claude L, Dieckmann K, Ermoian RP, Ford EC, Malet C, MacDonald SM, Nechesnyuk AV, Nilsson K, Villar RC, Winey BA, Tryggestad EJ, Terezakis SA.

Pract Radiat Oncol. 2014 Sep-Oct;4(5):336-41. doi: 10.1016/j.prro.2014.03.014. Epub 2014 May 14.

16.

Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?

Matney J, Park PC, Bluett J, Chen YP, Liu W, Court LE, Liao Z, Li H, Mohan R.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):576-82. doi: 10.1016/j.ijrobp.2013.07.007.

17.

[Proton beam therapy].

Ogino T.

Gan To Kagaku Ryoho. 2006 Apr;33(4):450-4. Japanese.

PMID:
16612152
18.

Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1336-42. doi: 10.1016/j.ijrobp.2010.07.2001. Epub 2011 Apr 4.

19.

Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview.

Weber DC, Ares C, Lomax AJ, Kurtz JM.

Radiat Oncol. 2006 Jul 20;1:22. Review.

20.

On the benefits and risks of proton therapy in pediatric craniopharyngioma.

Beltran C, Roca M, Merchant TE.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e281-7. doi: 10.1016/j.ijrobp.2011.01.005. Epub 2011 May 11.

Supplemental Content

Support Center